Acrivon Therapeutics
ACRV
#8030
Rank
A$0.33 B
Marketcap
$10.72
Share price
0.30%
Change (1 day)
46.11%
Change (1 year)

Acrivon Therapeutics (ACRV) - Cash on Hand

Cash on Hand as of September 2024 : A$0.29 Billion

According to Acrivon Therapeutics's latest financial reports the company has A$0.29 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Acrivon Therapeutics - Cash on Hand chart (from 2021 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$0.18 B36.64%
2021-12-31A$0.13 B6573.47%
2020-12-31A$2.05 M